TD Asset Management’s Minerva Neurosciences NERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-33,247
| Closed | -$200K | – | 1392 |
|
|
2020
Q1 | $200K | Sell |
33,247
-15,800
| -32% | -$95K | ﹤0.01% | 1316 |
|
|
2019
Q4 | $349K | Sell |
49,047
-1,200
| -2% | -$8.54K | ﹤0.01% | 1298 |
|
|
2019
Q3 | $389K | Sell |
50,247
-8,600
| -15% | -$66.6K | ﹤0.01% | 1215 |
|
|
2019
Q2 | $331K | Buy |
58,847
+1,600
| +3% | +$9K | ﹤0.01% | 1234 |
|
|
2019
Q1 | $450K | Buy |
57,247
+5,654
| +11% | +$44.4K | ﹤0.01% | 1199 |
|
|
2018
Q4 | $348K | Buy |
51,593
+1,500
| +3% | +$10.1K | ﹤0.01% | 1286 |
|
|
2018
Q3 | $629K | Buy |
50,093
+300
| +0.6% | +$3.77K | ﹤0.01% | 1248 |
|
|
2018
Q2 | $411K | Hold |
49,793
| – | – | ﹤0.01% | 1301 |
|
|
2018
Q1 | $311K | Hold |
49,793
| – | – | ﹤0.01% | 1275 |
|
|
2017
Q4 | $301K | Sell |
49,793
-300
| -0.6% | -$1.81K | ﹤0.01% | 1264 |
|
|
2017
Q3 | $381K | Sell |
50,093
-10,600
| -17% | -$80.6K | ﹤0.01% | 1201 |
|
|
2017
Q2 | $537K | Buy |
60,693
+33,593
| +124% | +$297K | ﹤0.01% | 1173 |
|
|
2017
Q1 | $220K | Buy |
27,100
+357
| +1% | +$2.9K | ﹤0.01% | 1361 |
|
|
2016
Q4 | $314K | Sell |
26,743
-1,033
| -4% | -$12.1K | ﹤0.01% | 1287 |
|
|
2016
Q3 | $392K | Buy |
+27,776
| New | +$392K | ﹤0.01% | 1243 |
|